A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation

Successful discontinuation of tyrosine kinase inhibitors has been achieved in patients with chronic-phase chronic myeloid leukemia (CML). Careful molecular monitoring after discontinuation warrants safe and prompt resumption of therapy. We retrospectively evaluated how molecular monitoring has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Dragani, Matteo, Rege Cambrin, Giovanna, Berchialla, Paola, Dogliotti, Irene, Rosti, Gianantonio, Castagnetti, Fausto, Capodanno, Isabella, Martino, Bruno, Cerrano, Marco, Ferrero, Dario, Gambacorti-Passerini, Carlo, Crugnola, Monica, Elena, Chiara, Breccia, Massimo, Iurlo, Alessandra, Cattaneo, Daniele, Galimberti, Sara, Gozzini, Antonella, Bocchia, Monica, Lunghi, Francesca, Cedrone, Michele, Sgherza, Nicola, Luciano, Luigia, Russo, Sabina, Santoro, Marco, Giai, Valentina, Caocci, Giovanni, Levato, Luciano, Abruzzese, Elisabetta, Sora, Federica, Saglio, Giuseppe, Fava, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698481/
https://www.ncbi.nlm.nih.gov/pubmed/33213044
http://dx.doi.org/10.3390/jcm9113692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698481/
https://www.ncbi.nlm.nih.gov/pubmed/33213044
http://dx.doi.org/10.3390/jcm9113692

Ejemplares similares